BDBM616848 6-(4-chlorobenzyl)-5-methyl-2-(1-(4-phenylpiperazin-1-yl)ethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one ::US20230279008, Compound 20

SMILES Cc1[nH]c2nc(C(C)N3CCN(c4ccccc4)CC3)nn2c(=O)c1Cc1ccc(Cl)cc1

InChI Key InChIKey=BUMNTXKFFVGHNS-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 616848   

TargetProstaglandin reductase 2(Human)
National Health Research Institutes

US Patent
LigandChemical structure of BindingDB Monomer ID 616848BDBM616848(US20230279008, Compound 20 | 6-(4-chlorobenzyl)-5-...)
Affinity DataIC50: 17.2nMAssay Description:Exemplary compounds thus prepared were evaluated for their efficacy in inhibiting PTGR2. In vitro enzyme activity was measured to determine the half ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent

TargetProstaglandin reductase 2(Human)
National Health Research Institutes

US Patent
LigandChemical structure of BindingDB Monomer ID 616848BDBM616848(US20230279008, Compound 20 | 6-(4-chlorobenzyl)-5-...)
Affinity DataEC50:  161nMAssay Description:Exemplary compounds thus prepared were evaluated for their efficacy in inhibiting PTGR2. In vitro enzyme activity was measured to determine the half ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
US Patent